Momentum continues to build for bipartisan legislation that would help protect Americans’ access to pharmacist care as NACDS members urge Congressional action during the 2022 NACDS Total Store Expo in Boston.
NACDS Total Store Expo — “Tomorrow Happens Here” — welcomes NACDS chain and supplier members back to Boston with vibrant conference schedule, opportunities for connection and collaboration.
NACDS’ sustained “Pharmacies. The face of neighborhood healthcare.” campaign seeks to “prevent a rollback of government policies that have enhanced patients’ access to pharmacies during the pandemic”
NACDS today announced the appointment of Kate Ilahi and Whitney Jones, each in the role of director of Congressional relations.
Diverse NACDS chain and supplier members developed health and wellness recommendations that leverage the total store for the total person.
The importance of the issue is underscored given rising rates of COVID-19 fueled by Omicron subvariants.
NACDS today welcomed the announcement by the U.S. Food and Drug Administration (FDA) that it revised the Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), “to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid.”
The decision offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation.
NACDS’ sustained “Pharmacies. The face of neighborhood healthcare.” campaign tells the story of pharmacies’ effectiveness in serving the American public — in times of emergency and every day.
On Thursday, NACDS submitted a letter to the Biden Administration detailing five key recommendations to support a seamless transition of COVID-19 vaccinations from government-purchased product to commercially available supply — while maintaining patients’ critical access to care.
